Kawakami, J. and Morales, A. 2013. Clinical significance of suboptimal hormonal levels in men with prostate cancer treated with LHRH agonists. Canadian Urological Association Journal. 7, 3-4 (Apr. 2013), e226–30. DOI:https://doi.org/10.5489/cuaj.540.